Conference Overview

Digi-Tech Pharma 2017

Gone are the days when pharma companies were associated with just selling the drugs. With more competitions, a revolution in healthcare, and an increase in general public understanding of health, pharma companies are trying hard to keep up with the changing technologies in the pharma IT domain. About 70% of patients use the internet to obtain information on health, treatment regime, drug safety and efficacy. This certainly imposes a threat that patients may reject a drug or treatment they consider expensive and not effective. It is thus inevitable to disregard this changing environment. Cloud computing, Internet of things, Big data and translational Informatics are transforming the world and pharma industries not immune to this change. The pharma has been relatively in moving from business-to-business model to a business-to- consumer model, though few have finally accepted this trend and has been making progress in the digital transformation to bring the consumers closer them. But there still exists numerous challenges that the companies have to face during this transformation. There is still an uncertainty about the success of digitization. Unless the pharma companies are able to come up with strategies to keep up with the digital revolution in pharma information technology, they may lose the market and customer base to new innovative entrants in the field. In order to retain your customers pharmaceutical meetings or pharmaceutical conferences like this are playing a vital role in taking pharmaceutical information technology to the next level.

Digi-Tech Pharma 2017(Pharmaceutical technology conference 2017), will provide a platform to all its participants an opportunity to interact, share and discuss the digitalization of Pharma industry. Digi-Tech Pharma 2017(Pharmaceutical conferences 2017) will allow its participants to discuss the various challenges faced, new strategies, case studies and use of innovative ideas in the field of digital pharma IT. Also, to stay updated on the latest trends in digital, social media and mobile strategies required the overcome the obstructions in the transformation. This Digi-Tech Pharma is a unique platform in the Pharmaceutical Conferences which will allow IT leaders to share their technologies and strategies to help the pharma industries. In the Pharma events 2017, the Digi-Tech Pharma will offer opportunities to encourage partnerships and collaborations.

It gives us a great pleasure to welcoming you to this international Digital pharma conference of 2017, The DIGI-TECH PHARMA 2017.


Key Highlights

  • Digitally enabled business models
  • Big data analytics and pharma
  • Internet of things and pharma
  • Translational Informatics
  • Policy changes required for ensuring smooth transition
  • Ensuring regulatory compliance during the transformation
  • Digital marketing trends
  • Integrating Multichannel marketing and closed loop marketing
  • Digitalization of R& D using Big Data and IoT
  • New smart devices in manufacturing and supply chain
  • Clinical trials and digital world
  • Data management
  • Tools and strategies to engage with HCPs and patients and to win their confidence
  • Encouraging a customer–centric approach at all levels
  • Unrealized innovative potentials of digital era that pharma needs to focus on


Who should attend the conference

Pharmaceutical Conferences 2017

This event is designed for senior level attendees from various companies including pharmaceutical, biotechnological, biopharmaceutical, CRO’s, Diagnostics, solution provider and government institutions.


Attendees includes VPs, GMs, Directors, Heads and Managers of

  • Pharma sales and Marketing 
  • E-marketing
  • Digital innovative strategic planning
  • Regulatory  and pharmacovigilance
  • IT consultants
  • Clinical trials and data management
  • Translational informatics
  • Data storage and analysis
  • Contract outsourcing service providers
  • Multi-channel Management
  • Health care professionals
  • Health IT professionals

Speakers

There are plenty of opportunities to position yourself as a thought leader & showcase your company.

For enquiries on speaker opportunities please e-mail to speaker@corvusglobalevents.com

Tuesday - 25th April 2017

 

  • 08:30
  • Registration & Refreshments

  • 09:20
  • Chairperson's opening remarks

CHANGING HEALTH & DIGITAL WORLD

  • 09:30
  • A decade of digital pharma 2006 - 2017: How far have we reached and the path forward?  

    • Progresses made towards digital transformation: Was it a smooth ride?
    • Challenges conquered by the industry
    • Digitally enabled business models
    • Learning from other industries and verticals

    Tim Cave VP-Head Strategic Planning and Digital Practices,
    Global Medical Affairs, GlaxoSmithKline (UK)

  • 10:00
  • Transforming the organization by transforming to digital: A tough road ahead….

    • Company leadership and transformation
    • Need for communication specialists and up-to-date technologies
    • Hiring digital experts and collaborations
    • The need to be really quick in transforming at every level

    Carla ArrietaCorporate Communications Specialist, Roche Diabetes Care (Spain)

  • 10:30
  • Morning Coffee/Tea & Networking

  • 10:50
  • The healthcare payers are undergoing a transformation that is materially impacting the way they evaluate medications and develop formularies.

    Pharmaceutical companies need to adapt to their changing needs to continue to be successful.

    • What is the impact of digital on health economies?
    • How do Payers see digital in delivering health care (reducing costs and improving outcomes)?
    • Examine the needs and challenges of payers and review the existing NHS policy framework and future trends in digital in relation to payers.
    • What strategy has Eli Lilly and company adopted to align with payers’ needs – and what are opportunities for pharma in this context?

    Nadeem Ashraf,Digital Lead for Medical Affairs & PRA – Europe & Canada,
    Eli Lilly and Company (UK)


  • 11:20
  • A road towards digitally transformed Pharmacovigilance

    • What are the barriers that industry are facing today? – and where are the Regulators?
    • Will big data / digital health and cognitive computing improve patient safety?
    • How will a digitally transformed future shape the relationship between stakeholders?

    Martin Holm-Petersen,Head of pvtech, Navitas Life Sciences (Denmark)

  • 11:50
  • The Global Technology Outlook and its impact on the pharma industry

    Peter Waggett,Director Emerging Technology, IBM (UK)

  • 12:20
  • Networking & Luncheon

    Digitalization and R & D

  • 13:30
  • Importance of patient engagement in R&D: Beneficial or just a hype?

    • The changing patient behavior in the digital era
    • Why is it essential to be prompt in identifying and addressing the patients needs?
    • How will digitization help bring patients on board?
    • Progress made by companies so far
    • Strategies to be adopted to increase patient –company data flow

    Speaker TBCAppian

  • 14:00
  • Big data analytics in Pharma: Reshaping the R & D

    • Importance of big data in decision making
    • Paying attention on treatments for rare diseases
    • Need for data integration and collaborations for free flow of information

  • 14:30
  • Challenges in Big data and digital health transformation and the way forward

    • Reluctance to adopt digital in R & D
    • Breaking the age old conservative habits of pharma
    • Data integration
    • Creating digitally empowered work force

    Jonathan Sheldon,Global Vice President,Health Sciences, Oracle (UK)

  • 15:00
  • Afternoon Tea/Coffee

  • 15:30
  • Translational informatics and precision medicine

    • Importance of Translational informatics in R & D
    • Why is it necessary to adopt TI in the resource –constrained world?
    • Major purpose of using TI by the industry
    • Challenges ahead and moving forward
  • 16:00
  • Panel discussion: With huge data reserve and unparalleled flow of information are we jeopardizing patient privacy and infidentiality

    • Impact of IoT and Cloud on clinical research
    • Obstacle and complexities involved especially from the patient point of view.
    • How do we balance transparency, free flow of data and patient privacy? Where do we draw the line?

    Anand Das,Regional Client Partner, Pfizer (UK)

    Philipp M. Diesinger,Global Chief Data Scientist, Boehringer Ingelheim (Germany)

  • 16:50
  • Chairperson’s closing remarks

  • 17:00
  • Networking Drinks Session

BRING YOUR TEAM
Delegate Registration

Corvus Global Events recognises the value of learning in teams. There's so much great content!!!

Bring your team and get an extra discount. There are special group packages available. Please email to delegate@corvusglobalevents.comfor more details.

SPONSORSHIPS

Maximise Your Involvement through Sponsorship and Exhibition Opportunities Our Sponsors are an integral part of the CGE Conference and we want to ensure you receive the best possible results for your investment. Exhibiting and Sponsorship options are extensive, and packages can be tailor-made to suit your individual company's needs. Most packages include complimentary entry passes, targeted marketing to industry officials and executives, and bespoke networking opportunities.

For enquiries please e-mail to sponsor@corvusglobalevents.com

EXTEDO

EXTEDO's focus is on optimizing clients' eRegulatory business processes. The company's enabling technology, the EXTEDOsuite, is uniquet in that it covers the complete regulatory landscape including:Product Registration Planning & Tracking (XEVMPD & IDMP)Submission Publishing & Lifecycle Management (eCTD, CTD, NeeS, IMPD, CTA, eCopy, DMF, ASMF, VNeeS, CADDY, ePRISM, eIndex) Pharmacovigilance Management (SUSAR, ICSR, PSUR, E2B, MedDRA, SMQ, GvP, CIOMS, MedWatch, R3) andDocument Management
We offer configurable off-the-shelf products, as well as customized and integrated solutions compliant with Medical Product Dictionary. EXTEDO also provides EURS, the validation, review and approval software solution for the EMA and over 25 Regulatory Authorities worldwide. Today we serve more than 700 customers in 60 countries ranging from small companies to large multinational organizations. EXTEDO operates in the following areas of life sciences: pharmaceutical, biotech and biopharma, generics, homeopathics, medical devices, crop sciences and public sector. EXTEDO is recognized as one of the worldwide leaders in each of these areas of operation.

PARTNERS

Partnerships typically involve an exchange of value and frequently include online content, PR, advertising, online & event branding.

For enquiries please e-mail to mediapartner@corvusglobalevents.com

?>
bootstrap

Venue

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now